Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

3
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
3
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Exploring The Prognostic Role Of D-dimer Levels In Pancreatic Cancer: A Comprehensive Review Of Clinicopathological Associations.
  1. Home
  2. Research Domains
  3. Biomedical And Clinical Sciences
  4. Oncology And Carcinogenesis
  5. Predictive And Prognostic Markers
  6. Exploring The Prognostic Role Of D-dimer Levels In Pancreatic Cancer: A Comprehensive Review Of Clinicopathological Associations.

Related Experiment Video

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.4K

Exploring the Prognostic Role of D-dimer Levels in Pancreatic Cancer: A Comprehensive Review of Clinicopathological Associations.

Sparsh Dixit1, Chandrashekhar Mahakalkar1, Shivani Kshirsagar1

  • 1General Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

Cureus
|October 7, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Elevated D-dimer levels indicate a poorer prognosis for pancreatic cancer patients. This fibrin degradation product may serve as a valuable prognostic biomarker for improved patient outcomes.

Keywords:
coagulationd-dimerpancreatic cancerprognostic biomarker

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

736
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.2K

Related Experiment Videos

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.4K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

736
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.2K

Area of Science:

  • Oncology
  • Hematology
  • Biomarker Research

Background:

  • Pancreatic cancer has a poor prognosis due to late diagnosis and aggressive progression.
  • Prognostic biomarkers are essential for improving patient outcomes and treatment strategies.
  • D-dimer, a fibrin degradation product, is associated with coagulation abnormalities and shows potential as a cancer biomarker.

Purpose of the Study:

  • To comprehensively review the prognostic role of D-dimer levels in pancreatic cancer.
  • To synthesize current research on D-dimer and its clinicopathological associations in pancreatic cancer.
  • To explore the potential utility of D-dimer as a prognostic marker for pancreatic cancer.

Main Methods:

  • Systematic review and synthesis of existing research on D-dimer levels in pancreatic cancer.
survival outcomes
tumor progression
  • Analysis of clinicopathological associations between D-dimer and tumor characteristics (stage, grade, metastasis).
  • Evaluation of methodological challenges and standardization needs for D-dimer measurement.
  • Main Results:

    • Elevated D-dimer levels in pancreatic cancer patients correlate with poorer clinical outcomes.
    • Higher D-dimer levels are associated with reduced overall survival and increased disease progression.
    • D-dimer levels show correlations with tumor stage, grade, and metastatic spread.

    Conclusions:

    • D-dimer shows potential as a prognostic biomarker in pancreatic cancer, linked to adverse outcomes.
    • Standardized measurement protocols are needed to enhance the reliability of D-dimer as a biomarker.
    • Further research is required to validate D-dimer's clinical utility for risk stratification and personalized treatment planning.